These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17700217)
1. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas. Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217 [TBL] [Abstract][Full Text] [Related]
2. [Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease]. Zheng M; Li LZ; Jiang ZA; Li LH; Feng YG; Fu XH Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):198-202. PubMed ID: 28162170 [No Abstract] [Full Text] [Related]
3. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Khalangot M; Tronko M; Kravchenko V; Kovtun V Diabetes Res Clin Pract; 2009 Dec; 86(3):247-53. PubMed ID: 19796836 [TBL] [Abstract][Full Text] [Related]
4. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality. Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195 [TBL] [Abstract][Full Text] [Related]
5. Normal insulin response to short-term intense exercise is abolished in Type 2 diabetic patients treated with gliclazide. Szewieczek J; Dulawa J; Strzałkowska D; Batko-Szwaczka A; Hornik B J Diabetes Complications; 2009; 23(6):380-6. PubMed ID: 18394931 [TBL] [Abstract][Full Text] [Related]
6. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide]. Jennings PE; Belch JJ Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442 [TBL] [Abstract][Full Text] [Related]
7. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide. Szewieczek J; Dulawa J; Strzałkowska D; Hornik B; Kawecki G J Diabetes Complications; 2007; 21(2):101-7. PubMed ID: 17331858 [TBL] [Abstract][Full Text] [Related]
8. Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris. Hueb W; Uchida AH; Gersh BJ; Betti RT; Lopes N; Moffa PJ; Ferreira BM; Ramires JA; Wajchenberg BL Coron Artery Dis; 2007 Feb; 18(1):55-9. PubMed ID: 17172931 [TBL] [Abstract][Full Text] [Related]
9. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina. Edwards RJ; Redwood SR; Lambiase PD; Marber MS Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027 [TBL] [Abstract][Full Text] [Related]
10. Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris. Ovünç K Clin Cardiol; 2000 Jul; 23(7):535-9. PubMed ID: 10894443 [TBL] [Abstract][Full Text] [Related]
11. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084 [TBL] [Abstract][Full Text] [Related]
13. [Warm-up angina and the application of a KATP channel blocker]. Jiang ZA; Zheng M; Fu XH Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):821-4. PubMed ID: 20079222 [TBL] [Abstract][Full Text] [Related]
14. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia. Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S; Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894 [TBL] [Abstract][Full Text] [Related]
15. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients. Pogatsa G; Koltai MZ; Jermendy G; Simon J; Aranyi Z; Ballagi-Pordany G Acta Med Hung; 1992-1993; 49(1-2):39-51. PubMed ID: 1296186 [TBL] [Abstract][Full Text] [Related]
16. Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris. Lindhardt TB; Abedini S; Olesen RM; Haunsø S; Gadsbøll N Cardiology; 2006; 105(1):17-21. PubMed ID: 16166774 [TBL] [Abstract][Full Text] [Related]
17. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice. Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455 [TBL] [Abstract][Full Text] [Related]
18. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients. Wascher TC; Boes U Clin Physiol Funct Imaging; 2005 Jan; 25(1):40-6. PubMed ID: 15659079 [TBL] [Abstract][Full Text] [Related]
19. Sulphonylureas and cancer: a case-control study. Monami M; Lamanna C; Balzi D; Marchionni N; Mannucci E Acta Diabetol; 2009 Dec; 46(4):279-84. PubMed ID: 19082520 [TBL] [Abstract][Full Text] [Related]
20. Association of gliclazide and left ventricular mass in type 2 diabetic patients. Pan NH; Lee TM; Lin MS; Huang CL; Chang NC Diabetes Res Clin Pract; 2006 Nov; 74(2):121-8. PubMed ID: 16631274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]